Treatment of colon cancer with dendritic cells (DC) is one of the modern immunotherapy types. This is an opportunity to completely get rid of cancer or control the disease for a long time at an advanced stage.
Benign prostatic hyperplasia is one of the most common urological conditions in men, especially aged 50 and older. The number of cases of BPH is rapidly increasing worldwide.
Therapeutic radionuclides Lutetium-177-PSMA, Actinium-225-PSMA, and Radium-223 have been successfully used in the treatment of advanced prostate cancer.
A lung cancer vaccine is a modern opportunity to achieve cancer remission at any stage and reduce the risk of disease recurrence. The procedure is well tolerated and has practically no contraindications.
This treatment option is used for most cancers. Bladder cancer (BC) is one of the oncological diseases for which immunotherapy is highly effective.
The treatment of the fourth stage ovarian cancer is aimed at prolonging and improving the quality of life of patients and preventing or eliminating the development of complications.
Medulloblastoma, while most commonly associated with children, can also occur in adults, although it is much rarer. In adults, medulloblastoma accounts for less than 1% of all primary brain tumors
Dendritic cells are antigen-presenting cells (APCs) essential for triggering T cell responses. They capture antigens from pathogens or tumor cells and process them into smaller fragments.
Dendritic cell-based immunotherapy is the administration of individually manufactured vaccines based on the genetic characteristics of a tumor in a particular person.
The main principle of this treatment is the restoration of the body's own defenses, the immune system, and nonspecific antitumor mechanisms.
Dendritic cell therapy has become a component of modern immunotherapy for osteosarcoma, offering hope to patients at different stages of the disease
Immunotherapy for melanoma is the treatment of choice for patients with metastatic tumors, resistance to chemotherapeutic agents, and disease recurrence after the successful initial treatment.
Advances in treating lung cancer have led to improved survival rates, thereby extending the life expectancy of many cancer patients.
Dendritic cell therapy represents a transformative advancement in immunotherapy, redefining cancer treatment by empowering the immune system to precisely target malignant cells.
